# Eyebot

> Eyebot builds contactless, self-serve AI vision-testing kiosks that deliver a doctor-verified eyeglass prescription in about 90 seconds - no appointment, insurance, or optometrist visit required. Placed in malls, pharmacies, and retail vision centers, the roughly five-foot kiosks measure refraction with touch-free infrared technology while licensed tele-doctors review and approve each prescription. Founded in Boston in 2021 by optics engineer Matthias Hofmann, the company aims to make vision care as easy as buying shoes, and has raised roughly $29.6M including a $20M Series A led by General Catalyst.

- **Founded:** 2021
- **Headquarters:** Boston, Massachusetts, United States
- **Founders:** Matthias Hofmann (Co-founder & CEO), Jack Moldave (Co-founder & CTO)
- **Team size:** ~37 employees (approximate; directory estimates range ~24-37)
- **Products:** Eyebot self-serve vision kiosk, Tele-doctor prescription review, Retail eyewear integration
- **Notable:** Raised a $20M Series A led by General Catalyst (August 2025), bringing total funding to roughly $29.6M, Conducted 45,000+ free vision tests with a target of 500,000+ annually, Validated in IRB-approved studies with 2,500+ patients; FDA-registered

## Products & services

- **Eyebot self-serve vision kiosk** — A roughly five-foot, contactless AI kiosk that performs a free ~90-second vision test using a touch-free Gen2 infrared autorefractor plus on-screen visual acuity checks, lensometry (scans existing glasses), and patient history intake.
- **Tele-doctor prescription review** — Licensed optometrists and ophthalmologists remotely review each kiosk result and approve, deny, or refer the eyeglass prescription - keeping a human doctor in the loop rather than relying on AI to prescribe.
- **Retail eyewear integration** — Prescriptions are emailed to the patient and can be routed to retail partners for same-visit glasses fulfillment through partners such as Zenni Optical and The Framery by 1-800 Contacts.

## Achievements

- Raised a $20M Series A led by General Catalyst (August 2025), bringing total funding to roughly $29.6M
- Conducted 45,000+ free vision tests with a target of 500,000+ annually
- Validated in IRB-approved studies with 2,500+ patients; FDA-registered
- Deployed first live kiosk at Burlington Mall (October 2024) and expanded across New England
- Secured pilots and partnerships with Walmart, Sam's Club, and 1-800 Contacts

## Latest updates

- **2024-06** — Announced ~$6M seed round co-led by AlleyCorp and Ubiquity Ventures.
- **2024-10** — Launched first live kiosk at Burlington Mall and began a New England rollout.
- **2025-08** — Raised $20M Series A led by General Catalyst to expand vision-care access.
- **2025-12** — Began Walmart and Sam's Club kiosk pilot across select Pennsylvania optical locations.
- **2026-01** — Announced The Framery by 1-800 Contacts partnership at CES for an end-to-end optical experience.
- **2026-02** — American Optometric Association raised patient-safety and privacy concerns to regulators amid Eyebot's national expansion.
- **2026-06** — 1-800 Contacts' Framery deployed Eyebot kiosks in Utah malls.

## Links

- Website: https://eyebot.co
- LinkedIn: https://www.linkedin.com/company/eyebotvision

---

Profile page: https://yespress.io/eyebot
Published by YesPress — https://yespress.io
Last updated: 2026-07-21